Vanguard Group Inc Champions Oncology, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 307,002 shares of CSBR stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
307,002
Previous 307,002
-0.0%
Holding current value
$2.49 Million
Previous $1.59 Million
5.8%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CSBR
# of Institutions
25Shares Held
5.82MCall Options Held
0Put Options Held
15K-
Battery Management Corp. Boston, MA2.42MShares$19.6 Million3.63% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$13.9 Million0.64% of portfolio
-
Tocqueville Asset Management L.P. New York, NY705KShares$5.72 Million0.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny120KShares$973,1270.0% of portfolio
-
Black Rock Inc. New York, NY116KShares$941,3430.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $110M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...